Drugs / Platelet Concentrate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable1 trial | ||||||
| — | NCT03196310 | Sep 2018 → Mar 2025 | osteoarthritis, hand | Kettering Health Network | Terminated | No outcome recorded Stop: Enrollment |
| Comparator or background therapy3 trials | ||||||
| Phase 3 | NCT03492515 Comparator | May 2018 → May 2020 | autoimmune thrombocytopenia | Shandong University | Unknown | No outcome recorded |
| Phase 4 | NCT05667805 Comparator | Jan 2023 → Jan 2027 expected | cirrhosis of liver | Medical University of Vienna | Recruiting | No outcome recorded |
| Phase 4 | NCT01955811 Background | Dec 2012 → Aug 2014 | — | Medical University Innsbruck | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Platelet Concentrate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05667805 ↗ |
| Modality | Other / unclassified | “Platelet Rich plasma” NCT03196310 ↗ |
| Route | Other | “Intra-articular injection of platelet rich plasma.” NCT03196310 ↗ |